254 related articles for article (PubMed ID: 17574403)
1. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):283-8. PubMed ID: 17574403
[TBL] [Abstract][Full Text] [Related]
2. Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients.
Vogt M; Kunath K; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):330-7. PubMed ID: 17574401
[TBL] [Abstract][Full Text] [Related]
3. Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs.
Vogt M; Vertzoni M; Kunath K; Reppas C; Dressman JB
Eur J Pharm Biopharm; 2008 Feb; 68(2):338-45. PubMed ID: 17646091
[TBL] [Abstract][Full Text] [Related]
4. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
Caron V; Tajber L; Corrigan OI; Healy AM
Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
[TBL] [Abstract][Full Text] [Related]
5. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
Hu J; Ng WK; Dong Y; Shen S; Tan RB
Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
[TBL] [Abstract][Full Text] [Related]
6. Effect of powder processing on performance of fenofibrate formulations.
Jain RA; Brito L; Straub JA; Tessier T; Bernstein H
Eur J Pharm Biopharm; 2008 Jun; 69(2):727-34. PubMed ID: 18226885
[TBL] [Abstract][Full Text] [Related]
7. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
Int J Pharm; 2007 May; 336(1):22-34. PubMed ID: 17174493
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
[TBL] [Abstract][Full Text] [Related]
9. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
Hugo M; Kunath K; Dressman J
Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.
Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG
Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807
[TBL] [Abstract][Full Text] [Related]
11. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
[TBL] [Abstract][Full Text] [Related]
12. Solid dispersion prepared by continuous cogrinding in an air jet mill.
Muehlenfeld C; Kann B; Windbergs M; Thommes M
J Pharm Sci; 2013 Nov; 102(11):4132-9. PubMed ID: 24105729
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
Hecq J; Deleers M; Fanara D; Vranckx H; Amighi K
Int J Pharm; 2005 Aug; 299(1-2):167-77. PubMed ID: 15996838
[TBL] [Abstract][Full Text] [Related]
14. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
[TBL] [Abstract][Full Text] [Related]
15. Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: spray-freezing into liquid with atmospheric freeze-drying.
Rogers TL; Nelsen AC; Sarkari M; Young TJ; Johnston KP; Williams RO
Pharm Res; 2003 Mar; 20(3):485-93. PubMed ID: 12669973
[TBL] [Abstract][Full Text] [Related]
16. High drug load, stable, manufacturable and bioavailable fenofibrate formulations in mesoporous silica: a comparison of spray drying versus solvent impregnation methods.
Hong S; Shen S; Tan DC; Ng WK; Liu X; Chia LS; Irwan AW; Tan R; Nowak SA; Marsh K; Gokhale R
Drug Deliv; 2016; 23(1):316-27. PubMed ID: 24853963
[TBL] [Abstract][Full Text] [Related]
17. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
Salazar J; Müller RH; Möschwitzer JP
Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
[TBL] [Abstract][Full Text] [Related]
19. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants.
Srinarong P; Faber JH; Visser MR; Hinrichs WL; Frijlink HW
Eur J Pharm Biopharm; 2009 Sep; 73(1):154-61. PubMed ID: 19465121
[TBL] [Abstract][Full Text] [Related]
20. Clay as a matrix former for spray drying of drug nanosuspensions.
Dong Y; Ng WK; Hu J; Shen S; Tan RB
Int J Pharm; 2014 Apr; 465(1-2):83-9. PubMed ID: 24560641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
